Journal of Antimicrobial Chemotherapy (2000) 45, 537-539
© 2000 The British Society for Antimicrobial Chemotherapy
Brief reports |
Clinical relevance of Proteus mirabilis in hospital patients: a two year survey
Laboratoire de Bactériologie, Faculté de Médecine, 28, place Henri Dunant, 63001 Clermont-Ferrand Cedex, France
A retrospective study was performed on 1072 non-duplicate isolates of Proteus mirabilis, taken in the period April 1996 to March 1998, and on 100 patient charts randomly selected during the same period. P. mirabilis isolates accounted for 7.7% of Enterobacteriaceae. The isolates were predominantly from urine (70.2%); of the total, 38.0% were penicillinase-producing isolates, 6.9% were extended-spectrum ß-lactamase (ESBL)-producing isolates and 3.6% produced inhibitor-resistant ß-lactamase (IRB). ESBL-producing isolates were observed in long-stay and intensive care and IRB-producing isolates in paediatric units. Of the 95 patients whose charts were examined, 69 had a confirmed infection, which in 42 cases was nosocomial.
* Corresponding author. Tel: +33-4-73-60-80-18; Fax: +33-4-73-27-74-94; E-mail: Christophe.DECHAMPS{at}u-clermont1.fr
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Saito, K. Sato, W. Kumita, N. Inami, H. Nishiyama, N. Okamura, K. Moriya, and K. Koike Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis J. Antimicrob. Chemother., September 1, 2006; 58(3): 673 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Luzzaro, M. Mezzatesta, C. Mugnaioli, M. Perilli, S. Stefani, G. Amicosante, G. M. Rossolini, and A. Toniolo Trends in Production of Extended-Spectrum {beta}-Lactamases among Enterobacteria of Medical Interest: Report of the Second Italian Nationwide Survey. J. Clin. Microbiol., May 1, 2006; 44(5): 1659 - 1664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Endimiani, F. Luzzaro, G. Brigante, M. Perilli, G. Lombardi, G. Amicosante, G. M. Rossolini, and A. Toniolo Proteus mirabilis Bloodstream Infections: Risk Factors and Treatment Outcome Related to the Expression of Extended-Spectrum {beta}-Lactamases Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2598 - 2605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagano, N. Shibata, Y. Saitou, Y. Nagano, and Y. Arakawa Nosocomial Outbreak of Infections by Proteus mirabilis That Produces Extended-Spectrum CTX-M-2 Type {beta}-Lactamase J. Clin. Microbiol., December 1, 2003; 41(12): 5530 - 5536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Naas, M. Zerbib, D. Girlich, and P. Nordmann Integration of a Transposon Tn1-Encoded Inhibitor-Resistant {beta}-Lactamase Gene, blaTEM-67 from Proteus mirabilis, into the Escherichia coli Chromosome Antimicrob. Agents Chemother., January 1, 2003; 47(1): 19 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H Mutnick, J. T Kirby, and R. N Jones CANCER Resistance Surveillance Program: Initial Results from Hematology-Oncology Centers in North America Ann. Pharmacother., January 1, 2003; 37(1): 47 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Weigel, G. J. Anderson, and F. C. Tenover DNA Gyrase and Topoisomerase IV Mutations Associated with Fluoroquinolone Resistance in Proteus mirabilis Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2582 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Spanu, F. Luzzaro, M. Perilli, G. Amicosante, A. Toniolo, and G. Fadda Occurrence of Extended-Spectrum {beta}-Lactamases in Members of the Family Enterobacteriaceae in Italy: Implications for Resistance to {beta}-Lactams and Other Antimicrobial Drugs Antimicrob. Agents Chemother., January 1, 2002; 46(1): 196 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. de Champs, C. Monne, R. Bonnet, W. Sougakoff, D. Sirot, C. Chanal, and J. Sirot New TEM Variant (TEM-92) Produced by Proteus mirabilis and Providencia stuartii Isolates Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1278 - 1280. [Abstract] [Full Text]
|
|
|
|
|
|
C. Chanal, R. Bonnet, C. De Champs, D. Sirot, R. Labia, and J. Sirot Prevalence of beta -Lactamases among 1,072 Clinical Strains of Proteus mirabilis: a 2-Year Survey in a French Hospital Antimicrob. Agents Chemother., July 1, 2000; 44(7): 1930 - 1935. [Abstract] [Full Text]
|
|